EMEA-001124-PIP01-10-M03

Key facts

Invented name
Lojuxta
Active substance
Lomitapide
Therapeutic area
Other
Decision number
P/0282/2015
PIP number
EMEA-001124-PIP01-10-M03
Pharmaceutical form(s)
  • Capsule, hard
  • Age-appropriate oral form
Condition(s) / indication(s)
Treatment of (heterozygous or homozygous) familial hypercholesterolaemia
Route(s) of administration
Oral use
Contact for public enquiries
Amryt Pharmaceuticals DAC

Tel. +44 1604 549 952
E-mail: medinfo@amrytpharma.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating